Shiga, H <br/><br/>
Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Dec 1999 
 - 4097-104 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1078-0432 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--biosynthesis<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Fluorouracil--administration & dosage<br/>Glutathione S-Transferase pi<br/>Glutathione Transferase--biosynthesis<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Isoenzymes--biosynthesis<br/>Male<br/>Middle Aged<br/>Neoadjuvant Therapy<br/>Paclitaxel--administration & dosage<br/>Retrospective Studies<br/>Thymidylate Synthase--biosynthesis<br/>Treatment Outcome<br/>Tumor Suppressor Protein p53--biosynthesis